Machine learning to classify clinically meaningful patient groups by ESAS symptom clusters in oropharyngeal cancer patients undergoing initial treatment.

Authors

null

Ghazal Haddad

Faculty of Medicine, University of Toronto, Toronto, ON, Canada

Ghazal Haddad, Katrina Hueniken, Scott Victor Bratman, John R de Almeida, David Paul Goldstein, Shao Hui Huang, Aaron Richard Hansen, Andrew J. Hope, Anna Spreafico, Wei Xu, Geoffrey Liu

Organizations

Faculty of Medicine, University of Toronto, Toronto, ON, Canada, Princess Margaret Cancer Centre, Toronto, ON, Canada, Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada, Department of Otolaryngology-Head & Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

Research Funding

Other
McLaughlin Scholarship at the University of Toronto.

Background: Cancer patients often experience symptoms in clusters, which could contribute to patient outcomes and quality of life; yet most analyses describe only individual symptom scores or a summation of symptom scores rather than symptom clusters. We compared machine learning to traditional statistical methods for grouping patients by symptoms in a heavy symptom burden patient population: oropharyngeal cancer patients undergoing initial treatment with radiation or chemoradiation (C/RT). Methods: K-means clustering was compared to traditional statistical methods (i.e., histogram-analysis; use of quantiles; categorization by clinico-demographic features) for classifying patients based on Edmonton Symptom Assessment System (ESAS) symptom scores in newly diagnosed oropharyngeal cancer patients before and after C/RT initiation. Results: 278 patients were classified into 3 K-means groups at each of two timepoints: pre-C/RT and post-C/RT. These groupings were formed primarily based on differences by symptom burden and were thus labeled: low, moderate, and high symptom-burden patient groups. The table shows dynamic change as patients moved from group to group during C/RT treatment. Greatest symptom-burdens in pre-C/RT patients were anxiety and tiredness; in post-C/RT, poor appetite and tiredness. Chi-squared residuals attributed being female (residuals of -3.95 for low, -2.46 for moderate, and 2.41 for high burden) and HPV-negative cancer (residuals of -1.48, -0.52, and 2.57, respectively) to being associated with higher symptom burden pre-C/RT; no clinico-demographic characteristics were associated with high symptom burden post-C/RT, suggesting this was a previously unidentified patient group. Although separation into K-means clusters in this population was primarily related to symptom burden, K-means better identified the number of patient groups and classified patients at the boundaries between groups (involving up to a quarter of patients) when compared to traditional statistical methods. Conclusions: Machine learning clustering analysis separated patients into discrete groups by symptom burden. K-means provided an objective means for clustering patients in a clinically-meaningful way when compared to traditional statistical methods for grouping patients.

Pre-C/RT Symptom GroupPost-C/RT LowPost-C/RT ModeratePost-C/RT High
Low - 164 (100%)80 (49%)70 (43%)14 (8.5%)
Moderate - 68 (100%)18 (26%)35 (51%)15 (22%)
High - 46 (100%)6 (13%)27 (59%)13 (28%)

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

On-Demand Poster Session: Patient Experience

Track

Patient Experience

Sub Track

Symptom Prevention, Assessment, and Management

Citation

J Clin Oncol 38, 2020 (suppl 29; abstr 171)

DOI

10.1200/JCO.2020.38.29_suppl.171

Abstract #

171

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

First Author: Loretta A. Williams

First Author: Elif Andac-Jones

Abstract

2023 ASCO Quality Care Symposium

Fatigue in patients with cancer treated on immunotherapy-based early phase clinical trials.

First Author: Jibran Ahmed